Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sapiens Reports Year-Over-Year Organic Revenue Growth of 20% for the First 9 Months of 2013

FORM, FORTY, SPNS

Q3 2013 Revenue Reaches a Record of $34.6 Million

HOLON, Israel, Nov. 6, 2013 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector, and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), announced today its financial results for the third quarter and nine months ended September 30, 2013.

(Logo: http://photos.prnewswire.com/prnh/20120508/531104 )

Third Quarter Financial and Business Highlights include:

  • Revenue increased by 17% to $34.6 million, compared to $29.6 million in the third quarter of 2012
  • Non- GAAP operating profit reached $3.6 million compared to $4.1 million in the third quarter of 2012
  • Non-GAAP net income attributable to Sapiens' shareholders reached $4.1 million, compared to $4.3 million in the third quarter of 2012, primarily due to an increase of 21% (on a non-GAAP basis) in investments in research and development, aimed at expanding our market-leading position
  • We increased our pipeline and signed several new agreements, including with Clal Insurance for our L&P solution and a deal with MLOZ for our P&C solution
  • Cash and cash equivalents at quarter end totaled $28.1 million, and we have no outstanding financial debt.

Roni Al-Dor, President and CEO of Sapiens, commented: "Our third quarter ended with a record top line result, representing a 20% year-over-year revenue growth in the first nine months of 2013 compared to the first nine months of 2012. We have signed new contracts in North America, Europe and Asia Pacific, involving all of our product lines – P&C, L&P, Reinsurance and DECISION. Because we have seen record booking orders, and signed agreements with multiple new customers, we feel that we have created a strong financial foundation for future growth."

Mr. Al-Dor continued, "Sapiens' growth engines are ranked at the top of the market. In a recent report by Celent, the Sapiens' L&P solution has been awarded an XCelent award in EMEA for being the leader in terms of functionality and is also recognised as a strong performer in terms of technology. Furthermore, in the North American market, Celent has observed that the Sapiens L&P solution has achieved one of the highest client growth rates for the period between 2011 and 2013 when compared its peers. In addition, as has been recently published by Ovum, Sapiens' P&C solution has been ranked as one of the top three in Europe. Also, Sapiens' DECISION, as a pioneer in its technology, is gaining market traction and has been adopted by top-tier US financial services firms. This leadership is a direct result of our ongoing investment in excellent products and delivery capabilities, to which we are committed. This market recognition is improving our win rate of new business globally."

Mr. Al-Dor concluded: "We continue to be focused on growth and on increasing our customer base for long-term value. In addition, we continue to increase our investment in delivery capabilities, R&D and sales, which results in reduced gross profit and operating profit in the short term, but we believe will support future growth and result in greater market share. In summary, we are confident in our growth and reiterate our revenue guidance of $135 million for the full-year 2013."

Nine Months Financial Highlights include:

  • Revenue increased by 20% to $99.2 million, compared to $82.7 million for the same period in 2012
  • Non-GAAP gross profit increased to $40.9 million compared to $38.9 million for the same period in 2012, while gross margin decreased from 46.8% to 41.3%
  • Non-GAAP net income attributable to Sapiens' shareholders decreased to $10.3 million, compared to $11.0 million for the same period in 2012, mainly due to an increase in research and development and sales and marketing costs

Non-GAAP Financial Measures

This press release contains the following non-GAAP financial measures: Non-GAAP revenue, Non-GAAP gross profit, Non-GAAP operating income, Non-GAAP net income attributed to Sapiens shareholders, Non-GAAP basic and diluted earnings per share.

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

Management of the Company does not consider these non-GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures. In order to compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

 

U.S. Dollars in thousands, except per share amounts


















For the three months ended


For the nine months ended

U.S GAAP basis


9/30/2013


9/30/2012


9/30/2013


9/30/2012



(unaudited)


(unaudited)


(unaudited)


(unaudited)

Revenues


$   34,613


$     29,574


$   99,185


$  82,739

Gross profit


12,537


12,919


36,906


35,355

Operating profit


3,116


3,323


8,558


8,526

Net income attributable to Sapiens' shareholders 

2,873


3,474


8,183


8,464

Basic earnings per share


0.07


0.09


0.21


0.21

Diluted earning per share


0.07


0.08


0.20


0.20










NonGAAP









Revenues


$   34,613


$     29,549


$   99,185


$  83,058

Gross profit


13,868


13,956


40,936


38,871

Operating profit


3,592


4,145


10,291


11,168

Net income attributable to Sapiens' shareholders 

4,076


4,254


10,259


10,978

Basic earnings per share


0.10


0.11


0.26


0.28

Diluted earnings per share


0.10


0.10


0.25


0.26

 

About Sapiens
Sapiens International Corporation (NASDAQ and TASE: SPNS) is a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector. We offer core, end-to-end solutions for the general insurance, property & casualty, life, pension and annuities markets, and business decision management software, globally. We have a track record of over 30 years in delivering superior software solutions to more than 100 financial services organizations. Our team of more than 900 professionals operates through our fully-owned subsidiaries in North America, the United Kingdom, EMEA and Asia Pacific.

Investor Relations Contact: 

 

Contact:
James Carbonara, Regional Vice President
Hayden IR
Office: (646)-755-7412
e-Mail: James@haydenir.com


Moshe Shamir, VP Marketing
Sapiens International
Tel: +972-3-7902032
e-Mail: moshe.shamir@sapiens.com

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES




CONDENSED CONSOLIDATED STATEMENTS OF INCOME





U.S. dollars in thousands (except per share amounts)



























 Three months ended


Nine months ended



September 30,


September 30,



2013


2012


2013


2012



(unaudited)


(unaudited)


(unaudited)


(unaudited)










Revenue

$     34,613


$     29,574


$ 99,185


$ 82,739

Cost of revenue

22,076


16,655


62,279


47,384










Gross profit

12,537


12,919


36,906


35,355










Operating Expenses:









Research and development, net

2,900


2,830


9,078


7,575


Selling, marketing, general and administrative

6,521


6,766


19,270


19,254

Total operating expenses

9,421


9,596


28,348


26,829










Operating income

3,116


3,323


8,558


8,526










Financial income, net

(2)


(239)


(308)


(385)

Taxes and other expenses, net

227


43


654


424



















Net income

$       2,891


$       3,519


$    8,212


$    8,487










Attributable to non-controlling interest

18


45


29


23










Net income attributable to Sapiens' shareholders

$       2,873


$       3,474


$    8,183


$    8,464



















Basic earnings per share

$          0.07


$          0.09


$      0.21


$      0.21










Diluted earnings per share

$          0.07


$          0.08


$      0.20


$      0.20










Weighted average number of shares








outstanding used to compute:

















Basic earnings per share

39,302


40,294


39,043


39,771

Diluted earnings per share

41,729


42,230


41,297


41,733

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES





RECONCILIATION OF GAAP TO NON-GAAP RESULTS





U.S. dollars in thousands (except per share amounts)

























 Three months ended


Nine months ended



9/30/2013


9/30/2012


9/30/2013


9/30/2012

GAAP revenue


$  34,613


$  29,574


$  99,185


$   82,739

Valuation adjustment on acquired deferred revenue and long term contract

-


(25)


-


319

Non-GAAP revenue


$  34,613


$  29,549


$  99,185


$   83,058



















GAAP gross profit


$  12,537


$  12,919


$  36,906


$   35,355

Revenue adjustment


-


(25)


-


319

Amortization of capitalized software


1,108


857


3,370


2,566

Amortization of other intangible assets


223


205


660


631

Non-GAAP gross profit


$  13,868


$  13,956


$  40,936


$   38,871



















GAAP operating income


$    3,116


$    3,323


$    8,558


$     8,526

Gross profit adjustments


1,331


1,037


4,030


3,516

Capitalization of software development


(1,398)


(730)


(3,936)


(2,645)

Amortization of other intangible assets


298


357


940


1,305

Stock-based compensation


245


158


699


466

Non-GAAP operating income


$    3,592


$    4,145


$  10,291


$   11,168



















GAAP net income attributable to Sapiens' shareholders


$    2,873


$    3,474


$ 8,183


$     8,464

Operating income adjustments


476


822


1,733


2,642

Other


727


(42)


343


(128)

Non-GAAP net income attributable to Sapiens' shareholders


$    4,076


$    4,254


$  10,259


$   10,978




























Non-GAAP basic earnings per share 


$       0.10


$       0.11


$       0.26


$       0.28










Non-GAAP diluted earnings per share


$       0.10


$       0.10


$       0.25


$       0.26

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. dollars in thousands













September 30,


December 31,




2013


2012




(unaudited)


(unaudited)







ASSETS











CURRENT ASSETS:






Cash and cash equivalents


$ 28,111


$ 29,050


Restricted cash


320


536


Trade receivables, net


25,129


16,299


Other receivables and prepaid expenses


2,736


1,785


Deferred Taxes


2,053


2,750








Total current assets


58,349


50,420







LONG-TERM ASSETS:






Property and equipment, net


4,236


2,243


Severance pay fund


11,368


10,306


Other intangible assets, net


29,713


29,212


Other long-term assets


3,214


2,316


Goodwill


71,295


68,087








Total long-term assets


119,826


112,164







TOTAL ASSETS


$ 178,175


$ 162,584








LIABILITIES AND EQUITY











CURRENT LIABILITIES:






Trade payables


$ 7,601


$ 4,382


Accrued expenses and other liabilities


20,177


20,014


Deferred revenue


8,450


7,301








Total current liabilities


36,228


31,697







LONG-TERM LIABILITIES:






Other long-term liabilities


1,485


803


Accrued severance pay


12,986


11,645








Total long-term liabilities


14,471


12,448







EQUITY


127,476


118,439







TOTAL LIABILITIES AND EQUITY


$ 178,175


$ 162,584

 

SOURCE Sapiens International Corporation



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today